LAMEA Hospital-Acquired Infection Diagnostics Market Size, Share & Industry Trends Analysis Report By Product (Reagents & Consumables and Instrument), By Infection Type, By Application, By Test Type, By End User, By Country and Growth Forecast, 2022 - 2028

The Latin America, Middle East and Africa Hospital-Acquired Infection Diagnostics Market would witness market growth of 11.5% CAGR during the forecast period (2022-2028).

To cure patients and aid in recovery, modern healthcare uses a variety of invasive technologies and procedures. Infections have been linked to medical devices like catheters and ventilators. Central line-associated bloodstream infections, ventilator-associated pneumonia, and catheter-associated urinary tract infections are examples of healthcare-associated infections (HAIs). Surgical site infections are infections that occur at the surgical site. This is because the illnesses pose a significant risk to patient safety, the CDC and other healthcare institutions strives to check and prevent them.

When a catheter-associated urinary tract infection is suspected, the old catheter must be withdrawn and a urine sample taken from the newly inserted catheter, ideally before antibiotics are started. The steps have been demonstrated to increase microbiological specimen output. All catheters comprising central lines and urine catheters should be withdrawn if it is no longer needed as part of the standby precautions. Antibiotics for seven days are usually indicated for catheter-associated UTIs. The antibiotic prescription could be stretched to 10-14 days if there is a slow response or bacteremia. Antimicrobial catheters, antibiotic prophylaxis, and antimicrobial catheters, in some settings, can help prevent CAUTI.

The UAE has a solid healthcare infrastructure as one of the most economically developed and diverse marketplaces in the Middle East region. The UAE government has prioritized the development of world-class healthcare infrastructure, and as a result, the sector has grown and expanded greatly in recent years. In addition, the UAE healthcare sector has grown to satisfy the country's changing demands as well as its desire to become a regional medical tourism destination. As the prevalence of lifestyle diseases rises, the populations, whose incomes are relatively high, continue to seek higher-quality healthcare. The government has committed to building healthcare infrastructure to accommodate the need.

They are liberalizing rules in order to attract international investment and better the healthcare standard and industry. The concerned authority wants to enhance health-care funding so that more data monitoring tools can be used for proactive COVID contact tracing and virtual medical service providers can be licensed. The government also intends to strengthen national capacities to combat future pandemics, including vaccine and pharmaceutical development, digital immunization IDs, and a new supply chain strategy. The Ministry of Health wants to grow the industry by concentrating on health information technology, such as telemedicine and digital medicine.

The Brazil market dominated the LAMEA Hospital-Acquired Infection Diagnostics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $115 million by 2028. The Argentina market is experiencing a CAGR of 12.1% during (2022 - 2028). Additionally, The UAE market would exhibit a CAGR of 11.2% during (2022 - 2028).

Based on Product, the market is segmented into Reagents & Consumables and Instrument. Based on Infection Type, the market is segmented into Urinary Tract Infections (UTI), Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, and Others. Based on Application, the market is segmented into Drug-Resistance Testing and Disease Testing. Based on Test Type, the market is segmented into Molecular Diagnostics, Immunoassay, and Urinalysis. Based on End User, the market is segmented into Hospital, Standalone Laboratories, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Hospital-Acquired Infection Diagnostics Market is Predict to reach $5.6 Billion by 2028, at a CAGR of 7.8%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG (Bayer Schering Pharma AG), Danaher Corporation, Becton, Dickinson and Company, Hologic, Inc., Ecolab, Inc., Pfizer, Inc., Steris PLC, Johnson & Johnson, Abbott Laboratories, and Merck Group.

Scope of the Study

Market Segments Covered in the Report:

By Product

• Reagents & Consumables
• Instrument

By Infection Type

• Urinary Tract Infections (UTI)
• Hospital Acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Others

By Application

• Drug-Resistance Testing
• Disease Testing

By Test Type

• Molecular Diagnostics
• Immunoassay
• Urinalysis

By End User

• Hospital
• Standalone Laboratories
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Bayer AG (Bayer Schering Pharma AG)
• Danaher Corporation
• Becton, Dickinson and Company
• Hologic, Inc.
• Ecolab, Inc.
• Pfizer, Inc.
• Steris PLC
• Johnson & Johnson
• Abbott Laboratories
• Merck Group

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Hospital-Acquired Infection Diagnostics Market, by Product
1.4.2 LAMEA Hospital-Acquired Infection Diagnostics Market, by Infection Type
1.4.3 LAMEA Hospital-Acquired Infection Diagnostics Market, by Application
1.4.4 LAMEA Hospital-Acquired Infection Diagnostics Market, by Test Type
1.4.5 LAMEA Hospital-Acquired Infection Diagnostics Market, by End User
1.4.6 LAMEA Hospital-Acquired Infection Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. LAMEA Hospital-Acquired Infection Diagnostics Market by Product
4.1 LAMEA Reagents & Consumables Market by Country
4.2 LAMEA Instrument Market by Country

Chapter 5. LAMEA Hospital-Acquired Infection Diagnostics Market by Infection Type
5.1 LAMEA Urinary Tract Infections (UTI) Market by Country
5.2 LAMEA Hospital Acquired Pneumonia Market by Country
5.3 LAMEA Bloodstream Infections Market by Country
5.4 LAMEA Surgical Site Infections Market by Country
5.5 LAMEA Gastrointestinal Infections Market by Country
5.6 LAMEA Others Market by Country

Chapter 6. LAMEA Hospital-Acquired Infection Diagnostics Market by Application
6.1 LAMEA Drug-Resistance Testing Market by Country
6.2 LAMEA Disease Testing Market by Country

Chapter 7. LAMEA Hospital-Acquired Infection Diagnostics Market by Test Type
7.1 LAMEA Molecular Diagnostics Market by Country
7.2 LAMEA Immunoassay Market by Country
7.3 LAMEA Urinalysis Market by Country

Chapter 8. LAMEA Hospital-Acquired Infection Diagnostics Market by End User
8.1 LAMEA Hospital Market by Country
8.2 LAMEA Standalone Laboratories Market by Country
8.3 LAMEA Others Market by Country

Chapter 9. LAMEA Hospital-Acquired Infection Diagnostics Market by Country
9.1 Brazil Hospital-Acquired Infection Diagnostics Market
9.1.1 Brazil Hospital-Acquired Infection Diagnostics Market by Product
9.1.2 Brazil Hospital-Acquired Infection Diagnostics Market by Infection Type
9.1.3 Brazil Hospital-Acquired Infection Diagnostics Market by Application
9.1.4 Brazil Hospital-Acquired Infection Diagnostics Market by Test Type
9.1.5 Brazil Hospital-Acquired Infection Diagnostics Market by End User
9.2 Argentina Hospital-Acquired Infection Diagnostics Market
9.2.1 Argentina Hospital-Acquired Infection Diagnostics Market by Product
9.2.2 Argentina Hospital-Acquired Infection Diagnostics Market by Infection Type
9.2.3 Argentina Hospital-Acquired Infection Diagnostics Market by Application
9.2.4 Argentina Hospital-Acquired Infection Diagnostics Market by Test Type
9.2.5 Argentina Hospital-Acquired Infection Diagnostics Market by End User
9.3 UAE Hospital-Acquired Infection Diagnostics Market
9.3.1 UAE Hospital-Acquired Infection Diagnostics Market by Product
9.3.2 UAE Hospital-Acquired Infection Diagnostics Market by Infection Type
9.3.3 UAE Hospital-Acquired Infection Diagnostics Market by Application
9.3.4 UAE Hospital-Acquired Infection Diagnostics Market by Test Type
9.3.5 UAE Hospital-Acquired Infection Diagnostics Market by End User
9.4 Saudi Arabia Hospital-Acquired Infection Diagnostics Market
9.4.1 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Product
9.4.2 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Infection Type
9.4.3 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Application
9.4.4 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Test Type
9.4.5 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by End User
9.5 South Africa Hospital-Acquired Infection Diagnostics Market
9.5.1 South Africa Hospital-Acquired Infection Diagnostics Market by Product
9.5.2 South Africa Hospital-Acquired Infection Diagnostics Market by Infection Type
9.5.3 South Africa Hospital-Acquired Infection Diagnostics Market by Application
9.5.4 South Africa Hospital-Acquired Infection Diagnostics Market by Test Type
9.5.5 South Africa Hospital-Acquired Infection Diagnostics Market by End User
9.6 Nigeria Hospital-Acquired Infection Diagnostics Market
9.6.1 Nigeria Hospital-Acquired Infection Diagnostics Market by Product
9.6.2 Nigeria Hospital-Acquired Infection Diagnostics Market by Infection Type
9.6.3 Nigeria Hospital-Acquired Infection Diagnostics Market by Application
9.6.4 Nigeria Hospital-Acquired Infection Diagnostics Market by Test Type
9.6.5 Nigeria Hospital-Acquired Infection Diagnostics Market by End User
9.7 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market
9.7.1 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Product
9.7.2 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Infection Type
9.7.3 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Application
9.7.4 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Test Type
9.7.5 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by End User

Chapter 10. Company Profiles
10.1 Bayer AG (Bayer Schering Pharma AG)
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent Strategies and Developments
10.1.5.1 Partnerships, Collaborations and Agreements
10.2 Danaher Corporation
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.3 Becton, Dickinson and Company
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.1 Recent Strategies and Developments
10.3.1.1 Partnerships, Collaborations and Agreements
10.3.1.2 Product Launches and Product Expansions
10.4 Hologic, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent Strategies and Developments
10.4.5.1 Partnerships, Collaborations and Agreements
10.4.5.2 Product Launches and Product Expansions
10.5 Ecolab, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent Strategies and Developments
10.5.5.1 Product Launches and Product Expansions:
10.5.5.2 Geographical Expansions:
10.6 Pfizer, Inc.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Regional & Segmental Analysis
10.6.4 Research & Development Expense
10.6.5 Recent Strategies and Developments
10.6.5.1 Approvals and Trials:
10.6.5.2 Acquisitions and Mergers
10.7 Steris PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.8 Johnson & Johnson
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental &Regional Analysis
10.8.4 Research & Development Expenses
10.9 Abbott Laboratories
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent Strategies and Developments
10.9.5.1 Approvals and Trials:
10.9.5.2 Product Launches and Product Expansions:
10.10. Merck Group
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental and Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent Strategies and Developments
10.10.5.1 Partnerships, Collaborations and Agreements

TABLE 1 LAMEA Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Hospital-Acquired Infection Diagnostics Market
TABLE 4 Product Launches And Product Expansions– Hospital-Acquired Infection Diagnostics Market
TABLE 5 Acquisition and Mergers– Hospital-Acquired Infection Diagnostics Market
TABLE 6 Approvals and Trials - Hospital-Acquired Infection Diagnostics Market
TABLE 7 LAMEA Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 8 LAMEA Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 9 LAMEA Reagents & Consumables Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Reagents & Consumables Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Instrument Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Instrument Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 14 LAMEA Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 15 LAMEA Urinary Tract Infections (UTI) Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Urinary Tract Infections (UTI) Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Hospital Acquired Pneumonia Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Hospital Acquired Pneumonia Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Bloodstream Infections Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Bloodstream Infections Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Surgical Site Infections Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Surgical Site Infections Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Gastrointestinal Infections Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Gastrointestinal Infections Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 28 LAMEA Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 29 LAMEA Drug-Resistance Testing Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Drug-Resistance Testing Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Disease Testing Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Disease Testing Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 34 LAMEA Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 35 LAMEA Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 36 LAMEA Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 37 LAMEA Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 38 LAMEA Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 39 LAMEA Urinalysis Market by Country, 2018 - 2021, USD Million
TABLE 40 LAMEA Urinalysis Market by Country, 2022 - 2028, USD Million
TABLE 41 LAMEA Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 42 LAMEA Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 43 LAMEA Hospital Market by Country, 2018 - 2021, USD Million
TABLE 44 LAMEA Hospital Market by Country, 2022 - 2028, USD Million
TABLE 45 LAMEA Standalone Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 46 LAMEA Standalone Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 47 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 48 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 49 LAMEA Hospital-Acquired Infection Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 50 LAMEA Hospital-Acquired Infection Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 51 Brazil Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 52 Brazil Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 53 Brazil Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 54 Brazil Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 55 Brazil Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 56 Brazil Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 57 Brazil Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 58 Brazil Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 59 Brazil Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 60 Brazil Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 61 Brazil Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 62 Brazil Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 63 Argentina Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 64 Argentina Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 65 Argentina Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 66 Argentina Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 67 Argentina Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 68 Argentina Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 69 Argentina Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 70 Argentina Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 71 Argentina Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 72 Argentina Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 73 Argentina Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 74 Argentina Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 75 UAE Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 76 UAE Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 77 UAE Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 78 UAE Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 79 UAE Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 80 UAE Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 81 UAE Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 82 UAE Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 83 UAE Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 84 UAE Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 85 UAE Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 86 UAE Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 87 Saudi Arabia Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 88 Saudi Arabia Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 89 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 90 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 91 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 92 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 93 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 94 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 95 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 96 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 97 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 98 Saudi Arabia Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 99 South Africa Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 100 South Africa Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 101 South Africa Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 102 South Africa Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 103 South Africa Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 104 South Africa Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 105 South Africa Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 106 South Africa Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 107 South Africa Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 108 South Africa Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 109 South Africa Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 110 South Africa Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 111 Nigeria Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 112 Nigeria Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 113 Nigeria Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 114 Nigeria Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 115 Nigeria Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 116 Nigeria Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 117 Nigeria Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 118 Nigeria Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 119 Nigeria Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 120 Nigeria Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 121 Nigeria Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 122 Nigeria Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 123 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market, 2018 - 2021, USD Million
TABLE 124 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market, 2022 - 2028, USD Million
TABLE 125 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 126 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 127 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Infection Type, 2018 - 2021, USD Million
TABLE 128 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Infection Type, 2022 - 2028, USD Million
TABLE 129 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 130 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 131 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 132 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 133 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by End User, 2018 - 2021, USD Million
TABLE 134 Rest of LAMEA Hospital-Acquired Infection Diagnostics Market by End User, 2022 - 2028, USD Million
TABLE 135 Key Information – Bayer AG
TABLE 136 Key Information – Danaher Corporation
TABLE 137 Key information – Becton, Dickinson and Company
TABLE 138 Key information – Hologic, Inc.
TABLE 139 Key Information – Ecolab, Inc.
TABLE 140 Key Information – Pfizer, Inc.
TABLE 141 key information – Steris PLC
TABLE 142 Key information – Johnson & Johnson
TABLE 143 Key Information – Abbott Laboratories
TABLE 144 key Information – Merck GrouP

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent Strategies and Developments: Becton, Dickinson and Company
FIG 5 Recent Strategies and Developments: Hologic, Inc.
FIG 6 Recent Strategies and Developments: Ecolab, Inc.
FIG 7 Recent Strategies and Developments: Pfizer, Inc.
FIG 8 Recent Strategies and Developments: Abbott Laboratories